Literature DB >> 30357532

Kago-Eye2 software for semi-automated segmentation of subfoveal choroid of optical coherence tomographic images.

Shozo Sonoda1, Hiroto Terasaki1, Naoko Kakiuchi1, Hideki Shiihara1, Tomonori Sakoguchi1, Masatoshi Tomita1, Yuki Shinohara1, Takehiro Yamashita1, Eisuke Uchino1, Taiji Sakamoto2.   

Abstract

PURPOSE: To determine the capabilities of the "Kago-Eye2" software to semi-automatically segment the choroid in the optical coherence tomographic (OCT) images. STUDY
DESIGN: A cross-sectional, prospective study of 44 healthy volunteers.
METHODS: The Kago-eye2 software was developed to detect the border between Choriocapillaris and Sattler's layer (C-S) and between Sattler's layer and Haller's layer (S-H). The intra- and inter-grader agreements were determined for the segmentations made with semi-automated and manual analysis using the Kago-Eye2 software. The inter-method agreements were determined for two independent graders.
RESULTS: Forty-four right eyes of 44 heathy volunteers (22 men) with a mean age of 35.0 ± 8.8 years were studied. The intra-grader agreement of the C-S border was 0.97 for grader 1 and 0.892 for grader 2 for the manual segmentation, and 0.908 for grader 1 and 0.842 for grader 2 for the Kago-Eye2 segmentation. For the S-H border, the intra-grader agreement was 0.96 for grader 1 and 0.981 for grader 2 for manual segmentation and 0.855 for grader 1 and 0.839 for grader 2 with the Kago-Eye2. For the C-S and S-H border, the inter-grader agreement was 0.548 and 0.902 for manual segmentation and 0.947 and 0.833 for the Kago-Eye2. The inter-method agreement was 0.565 for the C-S border and 0.759 for the S-H border.
CONCLUSION: The Kago-Eye2 software can segment the layers of the subfoveal choroid with good reproducibility and repeatability. We conclude that the Kago-Eye2 software can be used for semi-automatic segmentation of the choroidal layers.

Entities:  

Keywords:  Choroid; EDI-OCT; Image binarization; Kago-Eye2

Mesh:

Year:  2018        PMID: 30357532     DOI: 10.1007/s10384-018-0631-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  25 in total

1.  Repeatability and reproducibility of subfoveal choroidal thickness in normal eyes of Japanese using different SD-OCT devices.

Authors:  Toshifumi Yamashita; Takehiro Yamashita; Makoto Shirasawa; Noboru Arimura; Hiroto Terasaki; Taiji Sakamoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-01       Impact factor: 4.799

2.  Enhanced depth imaging spectral-domain optical coherence tomography.

Authors:  Richard F Spaide; Hideki Koizumi; Maria C Pozzoni; Maria C Pozonni
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

Review 3.  Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography - a review.

Authors:  Andrea Hassenstein; Carsten H Meyer
Journal:  Clin Exp Ophthalmol       Date:  2009-01       Impact factor: 4.207

4.  High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration.

Authors:  Monika Fleckenstein; Peter Charbel Issa; Hans-Martin Helb; Steffen Schmitz-Valckenberg; Robert P Finger; Hendrik P N Scholl; Karin U Loeffler; Frank G Holz
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

5.  Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images.

Authors:  Shozo Sonoda; Taiji Sakamoto; Takehiro Yamashita; Makoto Shirasawa; Eisuke Uchino; Hiroto Terasaki; Masatoshi Tomita
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-03       Impact factor: 4.799

6.  Variability of subfoveal choroidal thickness measurements in patients with age-related macular degeneration and central serous chorioretinopathy.

Authors:  J H Kim; S W Kang; J R Kim; S J Kim
Journal:  Eye (Lond)       Date:  2013-04-19       Impact factor: 3.775

7.  Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.

Authors:  Yutaka Imamura; Takamitsu Fujiwara; Ron Margolis; Richard F Spaide
Journal:  Retina       Date:  2009 Nov-Dec       Impact factor: 4.256

Review 8.  Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?

Authors:  Augustinus Laude; Peter D Cackett; Eranga N Vithana; Ian Y Yeo; Doric Wong; Adrian H Koh; Tien Y Wong; Tin Aung
Journal:  Prog Retin Eye Res       Date:  2009-10-23       Impact factor: 21.198

Review 9.  The multifunctional choroid.

Authors:  Debora L Nickla; Josh Wallman
Journal:  Prog Retin Eye Res       Date:  2009-12-29       Impact factor: 21.198

10.  Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab.

Authors:  Shozo Sonoda; Taiji Sakamoto; Hiroki Otsuka; Narimasa Yoshinaga; Toshifumi Yamashita; Yuya Ki-I; Akiko Okubo; Takehiro Yamashita; Noboru Arimura
Journal:  BMC Ophthalmol       Date:  2013-08-20       Impact factor: 2.209

View more
  3 in total

Review 1.  Choroidal imaging using optical coherence tomography: techniques and interpretations.

Authors:  Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2022-02-16       Impact factor: 2.447

2.  Automated Analysis of Choroidal Sublayer Morphologic Features in Myopic Children Using EDI-OCT by Deep Learning.

Authors:  Junmeng Li; Lei Zhu; Ruilin Zhu; Yanye Lu; Xin Rong; Yadi Zhang; Xiaopeng Gu; Yuwei Wang; Zhiyue Zhang; Qiushi Ren; Bei Rong; Liu Yang
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

3.  Livelayer: a semi-automatic software program for segmentation of layers and diabetic macular edema in optical coherence tomography images.

Authors:  Mansooreh Montazerin; Zahra Sajjadifar; Elias Khalili Pour; Hamid Riazi-Esfahani; Tahereh Mahmoudi; Hossein Rabbani; Hossein Movahedian; Alireza Dehghani; Mohammadreza Akhlaghi; Rahele Kafieh
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.